|
ZBTB39 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.043800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.064000E-03 |
| Normal-vs-Stage2 |
1.072300E-02 |
| Normal-vs-Stage3 |
2.49089999999619E-05 |
| Normal-vs-Stage4 |
2.034200E-04 |
| Stage1-vs-Stage2 |
6.807000E-01 |
| Stage1-vs-Stage3 |
3.796100E-02 |
| Stage1-vs-Stage4 |
6.158300E-02 |
| Stage2-vs-Stage3 |
2.809600E-01 |
| Stage2-vs-Stage4 |
3.206400E-01 |
| Stage3-vs-Stage4 |
9.959200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.402500E-04 |
| Normal-vs-AfricanAmerican |
2.565600E-02 |
| Normal-vs-Asian |
5.383600E-02 |
| Caucasian-vs-AfricanAmerican |
8.646200E-01 |
| Caucasian-vs-Asian |
3.989000E-01 |
| AfricanAmerican-vs-Asian |
4.636600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.318550E-03 |
| Normal-vs-Female |
2.973900E-04 |
| Male-vs-Female |
7.834400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.995100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.343060E-03 |
| Normal-vs-Age(61-80Yrs) |
2.383600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.245700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.018400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.648200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.121400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.343000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.894400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.253800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.613920E-02 |
| Classical-VS-Follicular |
3.020200E-04 |
| Classical-VS-Other |
7.886000E-01 |
| Classical-VS-Normal |
1.021780E-02 |
| Tall-VS-Follicular |
9.679400E-01 |
| Tall-VS-Other |
6.296000E-01 |
| Tall-VS-Normal |
8.35070000000382E-05 |
| Follicular-VS-Other |
6.349200E-01 |
| Follicular-VS-Normal |
3.90490000001797E-06 |
| Other-VS-Normal |
2.202400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.839660E-03 |
| Normal-vs-N1 |
1.204660E-04 |
| N0-vs-N1 |
1.702410E-01 |
|
|
